In glioblastoma, the heterogeneous expression of the Hippo pathway effector YAP led to cell competition, resulting in elimination of ‘low YAP’ tumour cells by ‘high YAP’ tumour cells; this process facilitated tumour progression [74]. Here, YAP1 is linked to glioblastoma.